Technology
  • Home
  • About
    • Overview
    • Management
    • Board of Directors
    • Advisors & Consultants
  • Technology
    • Overview
    • Commercial Applications
    • Videos
    • Research
    • Patent Portfolio
    • Consumer Products
  • Licensing Opportunities
  • Investors
    • Overview
    • News & Events
    • Presentations
    • Company Info
    • Analyst Coverage
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Legend Removal
    • Governance
  • Education
    • Background
    • Resources
    • General FAQs
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Presentations
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • 2022 Annual General Meeting
    • FAQ
  • Analyst Coverage
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • SEDAR
  • Legend Removal
  • Governance
    • Board of Directors
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jul 11, 2019 6:15am EDT

Lexaria Bioscience Enters CBD License Agreement with Universal Hemp

Jul 10, 2019 6:10am EDT

Lexaria Bioscience Enters CBD Beverage License Agreement with Nic’s Beverages

Jun 21, 2019 12:35pm EDT

Lexaria Announces 2019 Annual and Special Meeting Results

Jun 13, 2019 8:30am EDT

Lexaria Bioscience Corp. Featured in CannabisNewsAudio Broadcast on Dramatic Results of CBD Delivery System Study

Jun 12, 2019 8:35am EDT

Lexaria Bioscience Corp. Featured in CannabisNewsWire Publication Describing Dramatic CBD Delivery System Improvements

Jun 04, 2019 6:10am EDT

Lexaria Bioscience Announces new DehydraTECH Innovation, Files New Patents

May 31, 2019 8:30am EDT

Lexaria Bioscience Corp. Featured in CannabisNewsAudio Broadcast Touting Impact of Technology on CBD Edible Space

May 30, 2019 8:35am EDT

Lexaria Bioscience Corp. Featured in CannabisNewsWire Publication Discussing Disruptive Potential of CBD Delivery Technology

May 28, 2019 6:15am EDT

Combining Lexaria’s DehydraTECHTM with Nanotech Delivers Increased Quantities of CBD into Brain Tissue

May 21, 2019 6:05am EDT

Lexaria Bioscience and Nuka Enterprises' 1906 Expand Cannabis Product Relationship

  • Previous
  • 1…
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
medical cannabinoid research Lexaria Bioscience Corp. | Medical Cannabinoid Research | Home Logo

Lexaria Bioscience Corp. (NASDAQ:LEXX) has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules.

  • Home
  • About
  • Technology
  • Licensing Opportunities
  • Investors
  • News
  • Blog
  • Education
  • Events
  • Contact

250.765.6424
info@lexariabioscience.com

Lexaria Bioscience Corp.
#100-740 McCurdy Road
Kelowna, BC, V1X2P7

Privacy Policy

General Disclaimer:
No statement in this web site has been evaluated by the Food and Drug Administration (FDA). Furthermore, none of the statements in this web site should be construed as dispensing medical advice or making claims regarding the cure of diseases…

Read More

Copyright © 2022 All rights reserved. Web Design, Kelowna Photographers, SEO by Hiilite